H. Azukizawa

Publications64
h-index12
Citations896
Highly Influential Citations47
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • T. Shiohara
  • 329 Publications, 9,847 Citations
  • Y. Kano
  • 188 Publications, 3,558 Citations
  • I. Katayama
  • 711 Publications, 7,644 Citations
  • S. Nakagawa
  • 241 Publications, 5,779 Citations
  • Publications
  • Influence
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
IMPORTANCE The antiepileptic drug phenytoin can cause cutaneous adverse reactions, ranging from maculopapular exanthema to severe cutaneous adverse reactions, which include drug reactions with… Expand
  • 189
  • 10
  • PDF
Induction of T‐cell‐mediated skin disease specific for antigen transgenically expressed in keratinocytes
Transgenic mice were generated to establish an animal model for T‐cell‐mediated autoimmune skin disease. A membrane‐bound form of OVA (mOVA) was specifically expressed under the control of thekeratin… Expand
  • 83
  • 7
Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery.
Dendritic cells (DCs) are instrumental in the initiation of T cell responses, but how thymic and peripheral tolerogenic DCs differ globally from Toll-like receptor (TLR)-induced immunogenic DCs… Expand
  • 66
  • 7
Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Transcutaneous immunization (TCI) is an attractive vaccination method compared with conventional injectable vaccines because it is easier to administer without pain. We developed a dissolving… Expand
  • 110
  • 4
Sequelae in 145 patients with drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous…
Drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral… Expand
  • 63
  • 4
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens–Johnson syndrome and toxic epidermal necrolysis
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and life‐threatening cutaneous adverse drug reactions. While there is no established therapy for SJS/TEN, systemic… Expand
  • 42
  • 4
The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.
BACKGROUND Delayed hypersensitivity is responsible for severe cutaneous adverse drug reactions (cADRs), especially in Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis, and drug-induced… Expand
  • 38
  • 3
  • PDF
Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases.
BACKGROUND The impairment that pruritic skin diseases have on patient productivity at work, in the classroom, and in daily activities is substantial and needs to be characterized. The objective of… Expand
  • 44
  • 2
  • PDF
Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Microneedle (MN) patches have great potential as transcutaneous vaccine delivery devices because MNs can effectively deliver vaccine antigen into the skin through the micropores formed in the stratum… Expand
  • 16
  • 2
Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model.
It has been recognized that ceramides are decreased in the epidermis of patients with psoriasis and atopic dermatitis. Here, we generated Sptlc2 (serine palmitoyltransferase long-chain base subunit… Expand
  • 41
  • 1